-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Integra Lifesciences, Lowers Price Target to $15

Benzinga·10/14/2026 17:33:34
Listen to the news
Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price target from $19 to $15.